https://www.selleckchem.com/products/ABT-888.html
https://www.selleckchem.com/products/ABT-888.html
Study of the immobilization process pertaining to PFAS polluted earth. BACKGROUND This was a randomized, open-label, controlled phase II clinical trial to investigate the safety, efficacy, and outcomes of intrarenal artery infusion of autologous peripheral-blood-derived CD34+ cells for patients with chronic kidney disease (CKD; ie, stage III or IV). MATERIALS AND METHODS Between October 2016 and July 2018, 52 consecutive patients with CKD at stage III or IV were randomly allocated
Aimer
Commentaire
Partagez
